[托珠单抗成功治疗成年斯蒂尔病伴顽固性病情超过十年] - Suppr

Suppr

超能文献

[Successful tocilizumab therapy for adult onset Still's disease with intractable conditions over ten years].

作者信息

Takahashi Yuko, Ochi Hisako, Yanai Atsushi, Yamashita Hiroyuki, Itoh Kenji, Mimori Akio

机构信息

Division of Rheumatic Diseases, International Medical Center of Japan, Tokyo.

出版信息

Nihon Naika Gakkai Zasshi. 2010 Jan 10;99(1):130-2. doi: 10.2169/naika.99.130.

DOI:10.2169/naika.99.130

PMID:20196484

Abstract

摘要

相似文献

[Successful tocilizumab therapy for adult onset Still's disease with intractable conditions over ten years].

Nihon Naika Gakkai Zasshi. 2010 Jan 10;99(1):130-2. doi: 10.2169/naika.99.130.

Tocilizumab for multirefractory adult-onset Still's disease.

Ann Rheum Dis. 2009 Jan;68(1):153-4. doi: 10.1136/ard.2008.088179.

Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome.

Mod Rheumatol. 2011 Feb;21(1):92-6. doi: 10.1007/s10165-010-0348-9. Epub 2010 Aug 26.

A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years.

Mod Rheumatol. 2009;19(1):69-72. doi: 10.1007/s10165-008-0116-2. Epub 2008 Sep 2.

Successful treatment with tocilizumab in a patient with refractory adult-onset Still's disease (AOSD).

Clin Exp Rheumatol. 2010 Jan-Feb;28(1):141-2.

Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease.

Mod Rheumatol. 2016;26(2):297-301. doi: 10.3109/14397595.2014.899178. Epub 2014 Apr 3.

Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease.

Arthritis Rheum. 2002 Dec;46(12):3388-9. doi: 10.1002/art.10620.

[Antagonists of interleukin-6 (tocilizumab), in adult refractory still disease].

Presse Med. 2011 Jul-Aug;40(7-8):e333-7. doi: 10.1016/j.lpm.2011.03.012. Epub 2011 May 7.

Efficacy of tocilizumab in refractory adult-onset Still's disease; report of 2 cases.

Reumatol Clin. 2014 May-Jun;10(3):199-200. doi: 10.1016/j.reuma.2013.05.004. Epub 2013 Sep 27.

Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report.

Clin Exp Rheumatol. 2005 Sep-Oct;23(5):733.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Successful tocilizumab therapy for adult onset Still's disease with intractable conditions over ten years].

作者信息

Takahashi Yuko, Ochi Hisako, Yanai Atsushi, Yamashita Hiroyuki, Itoh Kenji, Mimori Akio

机构信息

Division of Rheumatic Diseases, International Medical Center of Japan, Tokyo.

出版信息

Nihon Naika Gakkai Zasshi. 2010 Jan 10;99(1):130-2. doi: 10.2169/naika.99.130.

DOI:10.2169/naika.99.130

PMID:20196484

Abstract

摘要

相似文献

[Successful tocilizumab therapy for adult onset Still's disease with intractable conditions over ten years].

Nihon Naika Gakkai Zasshi. 2010 Jan 10;99(1):130-2. doi: 10.2169/naika.99.130.

Tocilizumab for multirefractory adult-onset Still's disease.

Ann Rheum Dis. 2009 Jan;68(1):153-4. doi: 10.1136/ard.2008.088179.

Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome.

Mod Rheumatol. 2011 Feb;21(1):92-6. doi: 10.1007/s10165-010-0348-9. Epub 2010 Aug 26.

A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years.

Mod Rheumatol. 2009;19(1):69-72. doi: 10.1007/s10165-008-0116-2. Epub 2008 Sep 2.

Successful treatment with tocilizumab in a patient with refractory adult-onset Still's disease (AOSD).

Clin Exp Rheumatol. 2010 Jan-Feb;28(1):141-2.

Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease.

Mod Rheumatol. 2016;26(2):297-301. doi: 10.3109/14397595.2014.899178. Epub 2014 Apr 3.

Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease.

Arthritis Rheum. 2002 Dec;46(12):3388-9. doi: 10.1002/art.10620.

[Antagonists of interleukin-6 (tocilizumab), in adult refractory still disease].

Presse Med. 2011 Jul-Aug;40(7-8):e333-7. doi: 10.1016/j.lpm.2011.03.012. Epub 2011 May 7.

Efficacy of tocilizumab in refractory adult-onset Still's disease; report of 2 cases.

Reumatol Clin. 2014 May-Jun;10(3):199-200. doi: 10.1016/j.reuma.2013.05.004. Epub 2013 Sep 27.

Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report.

Clin Exp Rheumatol. 2005 Sep-Oct;23(5):733.